Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Background To limit the use of antimicrobials without disincentivising the development of novel antimicrobials, there is interest in establishing innovative models that fund antimicrobials based on an evaluation of their value as opposed to the volumes used. The aim of this project was to evaluate t...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Sue Harnan, Ben Kearns, Alison Scope, Laetitia Schmitt, Dina Jankovic, Jean Hamilton, Tushar Srivastava, Harry Hill, Chu Chang Ku, Shijie Ren, Claire Rothery, Laura Bojke, Mark Sculpher, Beth Woods
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	NIHR Journals Library 2024-10-01
Σειρά:	Health Technology Assessment
Θέματα:	ceftazidime-avibactam colistin drug resistance bacterial anti-bacterial agents cost-effectiveness analysis quality-adjusted life-years network meta-analysis oxacillinase expert testimony microbial sensitivity tests systematic review gram-negative bacterial infections
Διαθέσιμο Online:	https://doi.org/10.3310/YAPL9347
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!